Please assess the completion status of the following clinical trial:

Trial Title: To Assess Safety and Efficacy of Bolus Versus Continuous Infusion of Terlipressin in Acute Variceal Bleeding

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Any patient with only acute esophageal variceal bleeding (as defined by Asian pacific Association for the study of Liver Disease)~* Informed consent to participate in the study~* Age 18 to 70 years~Exclusion Criteria:~* Pregnant and lactation~* Prior treatment with any vasoactive drugs~* Significant heart or respiratory failure~* Peripheral arteriopathy clinically significant~* Previous heart stroke or significant alteration of the Electrocardiogram~* Hemodynamically unstable~* Refusal to participate in the study~* Hypertension

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 70 Years
- Healthy Volunteers: f

Study Arms:
- Bolus Terlipressin (Type: EXPERIMENTAL): Injection terlipressin after 2 mg bolus it will be given 2 mg QID
- Terlipressin continuous(4mg/24hours) (Type: ACTIVE_COMPARATOR): Injection terlipressin after 2 mg bolus it will be given 4 mg over 24 hours,and dose will be titrated as per HVPG (Hepatic Venous Pressure Gradient)

Based on this trial design, predict the completion outcome and termination type (if applicable).